Announce Date | 03/13/2024 |
EPS Normalized Actual | $0.96 (Beat by $1.06) |
EPS GAAP Actual | $0.96 (Beat by $1.06) |
Revenue Actual | $0.002069B |
Revenue Surprise | Beat by $2.069M |
Announce Date | 06/30/2024 (Pre-Market) |
EPS Normalized Estimate | $1.33835 |
EPS GAAP Estimate | $1.33835 |
Revenue Estimate | $0.001576B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2028 | 0.52 | 2.88 | 0.51629 | 0.52399 | 1 |
Dec 2027 | -0.225 | -6.67 | -0.22673 | -0.2234 | 0 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2022 (Mar 2022) | -1.01 | -0.21 | 0.002069B | -252.83% | -3.6M |
FQ4 2021 (Dec 2021) | -0.91 | -0.91 | 0.002744B | 30.5% | 2.74M |
FQ3 2021 (Sep 2021) | -0.7 | 0 | 0.003064B | -30.39% | 0M |
FQ2 2021 (Jun 2021) | -0.63 | 0.28 | 0.005148B | 66.45% | 0M |
FQ1 2021 (Mar 2021) | -0.66 | -0.05 | 0.0073B | 76.7% | 3.63M |
FQ4 2020 (Dec 2020) | -0.68 | -0.68 | 0.001907B | -90.35% | 1.91M |
FQ3 2020 (Sep 2020) | -0.86 | -0.86 | 0.003995B | -16.22% | 4M |
FQ2 2020 (Jun 2020) | -0.85 | -0.85 | 0.001727B | -24.84% | 1.73M |
FQ4 Announce Date
06/30/2024 (Pre-Market)
Consensus EPS Estimates
1.33835
Consensus Revenue Estimates
0.001576B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2025 (Sep 2025) | -0.245 | -- | -0.27707 | -0.18359 | 1 |
FQ2 2025 (Jun 2025) | -0.32 | -- | -0.36189 | -0.23978 | 1 |
FQ1 2025 (Mar 2025) | -0.25 | -- | -0.28273 | -0.18733 | 1 |
FQ3 2024 (Sep 2024) | 1.53737 | -- | 0.9273 | 2.44027 | 1 |
FQ2 2024 (Jun 2024) | 1.33835 | -- | 0.80726 | 2.12437 | 1 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2025 (Sep 2025) | 0.01B | -- | 0.01B | 0.01B | 0 |
FQ2 2025 (Jun 2025) | 0.02B | -- | 0.01B | 0.02B | 0 |
FQ1 2025 (Mar 2025) | 0.01B | -- | 0.01B | 0.01B | 0 |
FQ3 2024 (Sep 2024) | 0B | -- | 0B | 0B | 2 |
FQ2 2024 (Jun 2024) | 0B | -- | 0B | 0B | 2 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
1
EPS # of Misses
6
EPS # of in-lines
1
Revenue # of Beats
5
Revenue # of Misses
1
Revenue # of in-lines
2
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2022 (Mar 2022) | -0.8 | -1.01 | -0.21 | 20.79% |
FQ4 2021 (Dec 2021) | -0.91 | -0.91 | 100% | |
FQ3 2021 (Sep 2021) | -0.7 | -0.7 | 0 | 0% |
FQ2 2021 (Jun 2021) | -0.91 | -0.63 | 0.28 | -44.44% |
FQ1 2021 (Mar 2021) | -0.61 | -0.66 | -0.05 | 7.58% |
FQ4 2020 (Dec 2020) | -0.68 | -0.68 | 100% | |
FQ3 2020 (Sep 2020) | -0.86 | -0.86 | 100% | |
FQ2 2020 (Jun 2020) | -0.85 | -0.85 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2022 (Mar 2022) | $0.01B | $0B | $-3.6M | -174.05% |
FQ4 2021 (Dec 2021) | $0B | $0B | $2.74M | 100% |
FQ3 2021 (Sep 2021) | $0B | $0B | $0M | 0% |
FQ2 2021 (Jun 2021) | $0.01B | $0.01B | $0M | 0% |
FQ1 2021 (Mar 2021) | $0B | $0.01B | $3.63M | 49.73% |
FQ4 2020 (Dec 2020) | $0B | $0B | $1.91M | 100% |
FQ3 2020 (Sep 2020) | $0B | $0B | $4M | 100% |
FQ2 2020 (Jun 2020) | $0B | $0B | $1.73M | 100% |